FindTrial
Sign In

Construction of a prediction model for the prognosis of patients with malignant pleural and peritoneal mesothelioma.

Construction of a prediction model for the prognosis of patients with malignant pleural and peritoneal mesothelioma.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098791
Enrollment
Unknown
Registered
2025-03-13
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant pleural mesothelioma,malignant peritoneal mesothelioma

Interventions

malignant pleural mesothelioma:None
malignant peritoneal mesothelioma:None

Sponsors

Ningbo No.2 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.malignant pleural mesothelioma; 2.malignant peritoneal mesothelioma; 3.7 medical institutions: Ningbo First Hospital, Ningbo Second Hospital, Ningbo Yinzhou People's Hospital, Yuyao People's Hospital, Cixi People's Hospital, Women and Children's Hospital of Ningbo University and Yinzhou Second Hospital, a total of seven medical institutions in the past 10 years (January 1, 2014 to January 1, 2025) have been admitted to patients with pleural and peritoneal malignant mesothelioma; 4.male or female; 5.pathologically confirmed malignant mesothelioma;

Exclusion criteria

Exclusion criteria: 1.without histological diagonosis; 2.survival time from diagnosis to death less than 1 month; 3.incomplete follow-up data;

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
progression-free survival;—

Countries

China

Contacts

Public ContactFajiu Wang

Ningbo No.2 Hospital

wfjwyt@163.com+86 574 83871103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026